Biblio
A validated risk stratification that incorporates MAGIC biomarkers predicts long term outcomes in pediatric patients with acute GVHD. Transplant Cell Ther. 2024.
Ultra-high dose vitamin D in pediatric hematopoietic stem cell transplantation: A nonrandomized controlled trial. Transplant Cell Ther. 2021.
Prospective Multi-Institutional Study of Eculizumab to Treat High-Risk Stem Cell Transplant Associated TMA. Blood. 2023.
. Evaluation of elafin as a prognostic biomarker in acute graft-versus-host disease. Transplant Cell Ther. 2021.
A day 14 endpoint for acute GVHD clinical trials. Transplant Cell Ther. 2024.
COVID-19 Outcomes in Children, Adolescents and Young Adults with Cancer. Int J Cancer. 2022.
.